Loading
Geneticist known for work on the genetic drivers of childhood brain cancer who became Director and CEO of QIMR Berghofer, a leading Australian medical research institute, in 2026.
Professor Brandon Wainwright AM is Director and CEO of QIMR Berghofer Medical Research Institute in Brisbane, an Australian medical research institute with major cancer research programmes, a role he took up in 2026. He was previously Professor at The University of Queensland, led its Institute for Molecular Bioscience until 2019 and was Co-Director of the Children's Brain Cancer Centre. His research addresses genetic pathways in medulloblastoma and other cancers, including the role of Hedgehog signalling.
| Title | Journal | Year |
|---|---|---|
| Familial melanoma and p16 — a hung jury | Nature Genetics | 1994 |
| Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening | Neuro-Oncology | 2023 |
| Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model | Proceedings of the National Academy of Sciences | 2012 |
Shares Medulloblastoma and the tags leadership, clinician-scientist.
Shares Medulloblastoma and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist, genetics.
Shares the tags clinician-scientist, genetics.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.